0001437749-19-020880.txt : 20191109 0001437749-19-020880.hdr.sgml : 20191109 20191030091055 ACCESSION NUMBER: 0001437749-19-020880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191025 FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rishe Bryan CENTRAL INDEX KEY: 0001649328 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37799 FILM NUMBER: 191177995 MAIL ADDRESS: STREET 1: 1331 TYLER STREET NE STREET 2: SUITE 200 CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TACTILE SYSTEMS TECHNOLOGY INC CENTRAL INDEX KEY: 0001027838 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1331 TYLER STREET NE STE 200 CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 866-435-3948 MAIL ADDRESS: STREET 1: 1331 TYLER STREET NE STE 200 CITY: MINNEAPOLIS STATE: MN ZIP: 55413 4 1 rdgdoc.xml FORM 4 X0306 4 2019-10-25 0001027838 TACTILE SYSTEMS TECHNOLOGY INC TCMD 0001649328 Rishe Bryan 3701 WAYZATA BLVD. SUITE 300 MINNEAPOLIS MN 55416 1 SVP, Sales Common Stock 2019-10-25 4 M 0 4812 0.96 A 50674 D Common Stock 2019-10-25 4 S 0 4812 44.8836 D 45862 D Employee Stock Option (right to buy) 0.96 2019-10-25 4 M 0 4812 0 D 2023-10-13 Common Stock 4812 19250 D Stock option exercises and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2019. Reflects the weighted average price of 4,812 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on October 25, 2019 with sale prices ranging from $44.47 to $45.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Jonathan R. Zimmerman, Attorney-in-Fact 2019-10-29